Literature DB >> 25199621

Leptin administration activates irisin-induced myogenesis via nitric oxide-dependent mechanisms, but reduces its effect on subcutaneous fat browning in mice.

A Rodríguez1, S Becerril1, L Méndez-Giménez1, B Ramírez1, N Sáinz2, V Catalán1, J Gómez-Ambrosi1, G Frühbeck3.   

Abstract

UNLABELLED: BACKGROUND/OBJETIVES: Obese leptin-deficient ob/ob mice exhibit high adiposity and reduced muscle mass with leptin replacement promoting weight loss and inducing muscle accretion through PGC-1α-dependent mechanisms. Our aim was to analyze in vivo and in vitro the effect of leptin on FNDC5, a novel PGC-1α-dependent myokine that is synthesized and cleaved to form irisin that induces white adipose browning. METHODS/
RESULTS: Twelve-week-old male wild-type and ob/ob mice were divided in three groups as follows: control, leptin-treated (1 mg kg(-1) day(-1)) and pair-fed. Leptin administration was associated with increased gastrocnemius weight and cell surface area, higher Pgc1a and Fndc5 transcript levels and a slight increase in circulating irisin. Leptin upregulated Fndc5 expression through nitric oxide (NO)-dependent mechanisms in murine C2C12 myocytes and stimulated both basal and irisin-stimulated myogenesis, as evidenced by increased myocyte cell proliferation, higher myogenin and myonectin transcript levels together with lower mRNA expression of myostatin and dystrophin and the muscle atrophy-related factors MuRF1 and MAFbx. Interestingly, leptin downregulated Fndc5 expression in a NO-independent manner in murine differentiated subcutaneous adipocytes. Furthermore, leptin prevented the irisin-induced upregulation of both brown (Ucp1 and Cidec) and beige (Tmem26) adipocyte-specific genes and the increase in uncoupling protein-1-positive cells.
CONCLUSIONS: Taken together, our results provide evidence for a regulatory role of leptin on FNDC5/irisin, favoring muscle accretion but reducing fat browning.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25199621     DOI: 10.1038/ijo.2014.166

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  52 in total

Review 1.  Muscles, exercise and obesity: skeletal muscle as a secretory organ.

Authors:  Bente K Pedersen; Mark A Febbraio
Journal:  Nat Rev Endocrinol       Date:  2012-04-03       Impact factor: 43.330

2.  Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling.

Authors:  Yuan Zhang; Rui Li; Yan Meng; Shiwu Li; William Donelan; Yan Zhao; Lei Qi; Mingxiang Zhang; Xingli Wang; Taixing Cui; Li-Jun Yang; Dongqi Tang
Journal:  Diabetes       Date:  2013-10-22       Impact factor: 9.461

3.  Myogenin and class II HDACs control neurogenic muscle atrophy by inducing E3 ubiquitin ligases.

Authors:  Viviana Moresi; Andrew H Williams; Eric Meadows; Jesse M Flynn; Matthew J Potthoff; John McAnally; John M Shelton; Johannes Backs; William H Klein; James A Richardson; Rhonda Bassel-Duby; Eric N Olson
Journal:  Cell       Date:  2010-10-01       Impact factor: 41.582

4.  Acylated and desacyl ghrelin stimulate lipid accumulation in human visceral adipocytes.

Authors:  A Rodríguez; J Gómez-Ambrosi; V Catalán; M J Gil; S Becerril; N Sáinz; C Silva; J Salvador; I Colina; G Frühbeck
Journal:  Int J Obes (Lond)       Date:  2009-02-24       Impact factor: 5.095

5.  Leptin inhibits the proliferation of vascular smooth muscle cells induced by angiotensin II through nitric oxide-dependent mechanisms.

Authors:  Amaia Rodríguez; Javier Gómez-Ambrosi; Victoria Catalán; Ana Fortuño; Gema Frühbeck
Journal:  Mediators Inflamm       Date:  2010-06-01       Impact factor: 4.711

6.  Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies.

Authors:  Timea Kurdiova; Miroslav Balaz; Marek Vician; Denisa Maderova; Miroslav Vlcek; Ladislav Valkovic; Miroslav Srbecky; Richard Imrich; Olga Kyselovicova; Vitazoslav Belan; Ivan Jelok; Christian Wolfrum; Iwar Klimes; Martin Krssak; Erika Zemkova; Daniela Gasperikova; Jozef Ukropec; Barbara Ukropcova
Journal:  J Physiol       Date:  2013-12-02       Impact factor: 5.182

Review 7.  Role of PRDM16 in the activation of brown fat programming. Relevance to the development of obesity.

Authors:  Sara Becerril; Javier Gómez-Ambrosi; Marina Martín; Rafael Moncada; Pilar Sesma; María A Burrell; Gema Frühbeck
Journal:  Histol Histopathol       Date:  2013-06-17       Impact factor: 2.303

8.  Transcriptional analysis of brown adipose tissue in leptin-deficient mice lacking inducible nitric oxide synthase: evidence of the role of Med1 in energy balance.

Authors:  Sara Becerril; Amaia Rodríguez; Victoria Catalán; Neira Sáinz; Beatriz Ramírez; Javier Gómez-Ambrosi; Gema Frühbeck
Journal:  Physiol Genomics       Date:  2012-05-08       Impact factor: 3.107

Review 9.  Intracellular signalling pathways activated by leptin.

Authors:  Gema Frühbeck
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

10.  FNDC5/irisin is not only a myokine but also an adipokine.

Authors:  Arturo Roca-Rivada; Cecilia Castelao; Lucía L Senin; María O Landrove; Javier Baltar; Ana Belén Crujeiras; Luisa María Seoane; Felipe F Casanueva; María Pardo
Journal:  PLoS One       Date:  2013-04-11       Impact factor: 3.240

View more
  40 in total

Review 1.  Roles of myokines in exercise-induced improvement of neuropsychiatric function.

Authors:  Sujin Kim; Ji-Young Choi; Sohee Moon; Dong-Ho Park; Hyo-Bum Kwak; Ju-Hee Kang
Journal:  Pflugers Arch       Date:  2019-01-09       Impact factor: 3.657

Review 2.  Physiology and role of irisin in glucose homeostasis.

Authors:  Nikolaos Perakakis; Georgios A Triantafyllou; José Manuel Fernández-Real; Joo Young Huh; Kyung Hee Park; Jochen Seufert; Christos S Mantzoros
Journal:  Nat Rev Endocrinol       Date:  2017-02-17       Impact factor: 43.330

3.  Leptin-induced mitochondrial fusion mediates hepatic lipid accumulation.

Authors:  W-H Hsu; B-H Lee; T-M Pan
Journal:  Int J Obes (Lond)       Date:  2015-06-29       Impact factor: 5.095

4.  Myricanol modulates skeletal muscle-adipose tissue crosstalk to alleviate high-fat diet-induced obesity and insulin resistance.

Authors:  Shengnan Shen; Qiwen Liao; Tian Zhang; Ruile Pan; Ligen Lin
Journal:  Br J Pharmacol       Date:  2019-10-14       Impact factor: 8.739

5.  Plasma Complement C1q/tumor necrosis factor-related protein 15 concentration is associated with polycystic ovary syndrome.

Authors:  Akram Vatannejad; Reza Fadaei; Fouzieh Salimi; Fatima Zahraa Fouani; Behnam Habibi; Somayeh Shapourizadeh; Samira Eivazi; Sadegh Eivazi; Asie Sadeghi; Nariman Moradi
Journal:  PLoS One       Date:  2022-06-14       Impact factor: 3.752

6.  Leptin administration in physiological or pharmacological doses does not alter circulating irisin levels in humans.

Authors:  A Gavrieli; G Panagiotou; C S Mantzoros
Journal:  Int J Obes (Lond)       Date:  2016-05-20       Impact factor: 5.095

7.  What Is the Relationship Between Body Mass Index, Sex Hormones, Leptin, and Irisin in Children and Adolescents? A Path Analysis.

Authors:  Li Zhang; Xingwang Peng; Yuanyuan Wang; Ruiyao Cao; Zizhe Zhang; Lianguo Fu
Journal:  Front Pediatr       Date:  2022-04-15       Impact factor: 3.569

Review 8.  Irisin and Myonectin Regulation in the Insulin Resistant Muscle: Implications to Adipose Tissue: Muscle Crosstalk.

Authors:  Luis Gamas; Paulo Matafome; Raquel Seiça
Journal:  J Diabetes Res       Date:  2015-05-05       Impact factor: 4.011

9.  Circulating Levels of Betatrophin and Irisin Are Not Associated with Pancreatic β-Cell Function in Previously Diagnosed Type 2 Diabetes Mellitus Patients.

Authors:  Lingshu Wang; Jun Song; Chuan Wang; Peng Lin; Kai Liang; Yu Sun; Tianyi He; Wenjuan Li; Ruxing Zhao; Jun Qin; Yiran Lu; Jinbo Liu; Fuqiang Liu; Xinguo Hou; Li Chen
Journal:  J Diabetes Res       Date:  2015-11-16       Impact factor: 4.011

Review 10.  The Controversial Role of Irisin in Clinical Management of Coronary Heart Disease.

Authors:  Wen-Lu Ou-Yang; Bei Guo; Feng Xu; Xiao Lin; Fu-Xing-Zi Li; Su-Kang Shan; Feng Wu; Yi Wang; Ming-Hui Zheng; Qiu-Shuang Xu; Ling-Qing Yuan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-01       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.